首页> 外文期刊>Internal medicine. >Successful Treatment of a Case of Late-onset Colitis after Umbilical Cord Transplantation with Metronidazole: A Case Report and Literature Review
【24h】

Successful Treatment of a Case of Late-onset Colitis after Umbilical Cord Transplantation with Metronidazole: A Case Report and Literature Review

机译:甲硝唑成功治疗脐带移植后迟发性结肠炎:一例报道并文献复习

获取原文
           

摘要

Diarrhea after hematopoietic stem cell transplantation (HSCT) can be life-threatening, and its etiology includes conditioning regimens, graft-versus-host disease (GVHD), infections, and transplantation-associated microangiopathy (iTAM). Cord colitis syndrome (CCS) has been described as a syndrome of culture-negative and antibiotic-responsive persistent watery and non-bloody diarrhea of uncertain pathogenesis and occurs in umbilical cord blood transplantation (UCBT) recipients. We encountered a case similar to CCS that developed severe watery diarrhea after UCBT without any signs of GVHD or infection and responded well to metronidazole (MNZ) treatment. Since CCS is very rare, we herein describe a case of MNZ-effective diarrhea after UCBT.
机译:造血干细胞移植(HSCT)后的腹泻可能危及生命,其病因包括调理方案,移植物抗宿主病(GVHD),感染和移植相关的微血管病(iTAM)。脐带结肠炎综合征(CCS)已被描述为培养阴性且对抗生素反应敏感的持续性水样和非血性腹泻,其发病机理不确定,并发生于脐带血移植(UCBT)受者中。我们遇到了一个类似CCS的案例,该案例在UCBT后出现严重的水样腹泻,没有任何GVHD或感染迹象,并且对甲硝唑(MNZ)的治疗反应良好。由于CCS非常罕见,因此我们在此描述UCBT后发生MNZ有效腹泻的病例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号